Literature DB >> 18514254

Benzene-induced hematopoietic toxicity transmitted by AhR in wild-type mouse and nullified by repopulation with AhR-deficient bone marrow cells: time after benzene treatment and recovery.

Yoko Hirabayashi1, Byung-Il Yoon, Guang-Xun Li, Yoshiaki Fujii-Kuriyama, Toyozo Kaneko, Jun Kanno, Tohru Inoue.   

Abstract

Previously, we found an aryl hydrocarbon receptor (AhR)-transmitted benzene-induced hematotoxicity; that is, AhR-knockout (KO) mice did not show any hematotoxicity after benzene exposure [Yoon, B.I., Hirabayashi, Y., Kawasaki, Y., Kodama, Y., Kaneko, T., Kanno, J., Kim, D.Y., Fujii-Kuriyama, Y., Inoue, T., 2002. Aryl hydrocarbon receptor mediates benzene-induced hematotoxicity. Toxicol. Sci. 70, 150-156]. Furthermore, our preliminary study showed a significant attenuation of benzene-induced hematopoietic toxicity by AhR expression, when the bone marrow (BM) of mice was repopulated with AhR-KO BM cells [Hirabayashi, Y., Yoon, B.I., Li, G., Fujii-Kuriyama, Y., Kaneko, T., Kanno, J., Inoue, T., 2005a. Benzene-induced hematopoietic toxicity transmitted by AhR in the wild-type mouse was negated by repopulation of AhR deficient bone marrow cells. Organohalogen Comp. 67, 2280-2283]. In this study, benzene-induced hematotoxicity and its nullification by AhR-KO BM cells were further precisely reevaluated including the duration of the effect after benzene treatment and recovery after the cessation of exposure. Exposure routes, namely, intraperitoneal (i.p.) injection used in our previous study and intragastric (i.g.) administration used in this study, were also compared in terms of their toxicologic outcomes. From the results of this study, mice that had been lethally irradiated and repopulated with BM cells from AhR-KO mice essentially did not show any benzene-induced hematotoxicity. The AhR-KO BM cells nullified benzene-induced toxicities in notably different hematopoietic endpoints between the i.p. treatment and the i.g. treatment; however, the number of granulo-macrophage colony-forming unit in vitro (CFU-GM) was a common target parameter, the benzene-induced toxicity of which was nullified by the AhR-KO BM cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514254     DOI: 10.1016/j.chemosphere.2007.12.033

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  6 in total

Review 1.  Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment.

Authors:  Cliona M McHale; Luoping Zhang; Martyn T Smith
Journal:  Carcinogenesis       Date:  2011-12-12       Impact factor: 4.944

2.  Benzene toxicity: The role of the susceptibility factor NQO1 in bone marrow endothelial cell signaling and function.

Authors:  David Ross; Hongfei Zhou; David Siegel
Journal:  Chem Biol Interact       Date:  2010-10-21       Impact factor: 5.192

Review 3.  Advances in understanding benzene health effects and susceptibility.

Authors:  Martyn T Smith
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

Review 4.  The aryl hydrocarbon receptor has an important role in the regulation of hematopoiesis: implications for benzene-induced hematopoietic toxicity.

Authors:  Thomas A Gasiewicz; Kameshwar P Singh; Fanny L Casado
Journal:  Chem Biol Interact       Date:  2009-11-05       Impact factor: 5.192

5.  Assessment of benzene-induced hematotoxicity using a human-like hematopoietic lineage in NOD/Shi-scid/IL-2Rγnull mice.

Authors:  Masayuki Takahashi; Noriyuki Tsujimura; Tomoko Yoshino; Masahito Hosokawa; Kensuke Otsuka; Tadashi Matsunaga; Satoshi Nakasono
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

6.  Altered Expression of Genes in Signaling Pathways Regulating Proliferation of Hematopoietic Stem and Progenitor Cells in Mice with Subchronic Benzene Exposure.

Authors:  Rongli Sun; Juan Zhang; Mengzhen Xiong; Haiyan Wei; Kehong Tan; Lihong Yin; Yuepu Pu
Journal:  Int J Environ Res Public Health       Date:  2015-08-07       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.